These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 23669282
1. Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension. Berzigotti A, Reverter E, García-Criado A, Abraldes JG, Cerini F, García-Pagán JC, Bosch J. J Hepatol; 2013 Oct; 59(4):717-22. PubMed ID: 23669282 [Abstract] [Full Text] [Related]
2. Relationship between portal blood flow measured by image-directed Doppler ultrasonography and hepatic blood flow measured by indocyanine green constant infusion in patients with cirrhosis. Bolognesi M, Sacerdoti D, Merkel C, Gatta A. J Clin Ultrasound; 1995 Jun; 23(5):297-303. PubMed ID: 7642768 [Abstract] [Full Text] [Related]
3. Caval Subtraction 2D Phase-Contrast MRI to Measure Total Liver and Hepatic Arterial Blood Flow: Proof-of-Principle, Correlation With Portal Hypertension Severity and Validation in Patients With Chronic Liver Disease. Chouhan MD, Mookerjee RP, Bainbridge A, Punwani S, Jones H, Davies N, Walker-Samuel S, Patch D, Jalan R, Halligan S, Lythgoe MF, Taylor SA. Invest Radiol; 2017 Mar; 52(3):170-176. PubMed ID: 27805917 [Abstract] [Full Text] [Related]
4. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis. Pind ML, Bendtsen F, Kallemose T, Møller S. Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):948-54. PubMed ID: 27172450 [Abstract] [Full Text] [Related]
5. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. Kim MY, Baik SK, Park DH, Lim DW, Kim JW, Kim HS, Kwon SO, Kim YJ, Chang SJ, Lee SS. Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539 [Abstract] [Full Text] [Related]
6. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Radiology; 2003 Nov; 229(2):409-14. PubMed ID: 12970464 [Abstract] [Full Text] [Related]
8. Combined hepatic vein, umbilicoportal vein, and superior mesenteric artery catheterization in portal hypertension: estimation of the portal fraction of total hepatic blood flow in cirrhotic patients. Huet PM, Lavoie P, Légaré A, Viallet A. Yale J Biol Med; 1975 Mar; 48(1):55-66. PubMed ID: 1130101 [Abstract] [Full Text] [Related]
9. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients. Ottesen LH, Flyvbjerg A, Møller S, Bendtsen F. Aliment Pharmacol Ther; 1998 Jul; 12(7):657-65. PubMed ID: 9701530 [Abstract] [Full Text] [Related]
11. The value of Doppler ultrasound in cirrhosis and portal hypertension. Kok T, van der Jagt EJ, Haagsma EB, Bijleveld CM, Jansen PL, Boeve WJ. Scand J Gastroenterol Suppl; 1999 Jul; 230():82-8. PubMed ID: 10499467 [Abstract] [Full Text] [Related]
13. Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis. Choi YJ, Baik SK, Park DH, Kim MY, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW. J Gastroenterol Hepatol; 2003 Apr; 18(4):424-9. PubMed ID: 12653891 [Abstract] [Full Text] [Related]
14. [Computed sonography observation on the effects of cimetidine on the liver blood flow in cirrhotic patients with portal hypertension]. Li S, Hou H, Leng X. Zhonghua Wai Ke Za Zhi; 1995 Aug; 33(8):466-9. PubMed ID: 8706560 [Abstract] [Full Text] [Related]
15. Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension. Iwao T, Toyonaga A, Oho K, Tayama C, Masumoto H, Sakai T, Sato M, Tanikawa K. Am J Gastroenterol; 1997 Jun; 92(6):1012-7. PubMed ID: 9177521 [Abstract] [Full Text] [Related]
16. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model. Jiao LR, El-Desoky AA, Seifalian AM, Habib N, Davidson BR. Br J Surg; 2000 May; 87(5):568-74. PubMed ID: 10792311 [Abstract] [Full Text] [Related]
17. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension. Lisotti A, Azzaroli F, Cucchetti A, Buonfiglioli F, Cecinato P, Calvanese C, Simoni P, Arena R, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G. Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880 [Abstract] [Full Text] [Related]
18. Sorbitol as a test substance for measurement of liver plasma flow in humans. Keiding S, Engsted E, Ott P. Hepatology; 1998 Jul; 28(1):50-6. PubMed ID: 9657096 [Abstract] [Full Text] [Related]
20. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Cecinato P, Turco L, Calvanese C, Simoni P, Guardigli M, Arena R, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G. Hepatology; 2014 Feb; 59(2):643-50. PubMed ID: 24038116 [Abstract] [Full Text] [Related] Page: [Next] [New Search]